PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

A phase II clinical trial is larger and is used to determine if the treatment is effective. Depending on the prevalence of the type of cancer the treatment is designed for, up to 100 patients may ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...